| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |